Clinical Trial Update: Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Mild to Moderate Essential Hypertension [Phase 4]

View source ↗

Summary

Phase 4 efficacy study of nifedipine controlled-release tablets (Xin Ran) for essential hypertension has completed; the snippet does not report trial outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Xin Ran (nifedipine)

Snippet

Sponsor: Shanghai Shyndec Pharmaceutical Co., Ltd. | Conditions: Essential Hypertension | Phase 4 | Status: COMPLETED